ஹைடெக் கண்டறியும் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஹைடெக் கண்டறியும் மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஹைடெக் கண்டறியும் மையம் Today - Breaking & Trending Today

HCL Tech share price: Stocks in the news: HCL Tech, Maruti, HFCL, Fortis, Equitas SFB and Vedanta


Hindustan Unilever: The FMCG major said it has launched its first Smart Fill machine, an in-store vending model for its home care products to reuse, reduce and recycle plastic.
Maruti Suzuki India: The country s largest carmaker announced the nationwide roll-out of its digital platform that provides customers end-to-end online car financing solutions.
Fortis Healthcare: The healthcare facilities plans to initiate various measures like engaging with key corporate clients, leveraging digital platforms, and developing further competencies in cancer care, neuro and renal sciences, to improve margins and grow revenues this fiscal, as per the company s Annual Report for 2020-21.
Vedanta: The mining firm s Talwandi Sabo Power Ltd (TSPL) said that all three units of its 1,980 MW coal-fired thermal power plant in Mansa district of Punjab would be operational by the end of this month. In a statement, it stated that the TSPL engineers are on war footing to rectify a technical s ....

India General , Talwandi Sabo , Shyam Srinivasan , Pirojsha Godrej , Godrej Properties , Talwandi Sabo Power Ltd , Equitas Small Finance Bank , Dr Ganesan Hitech Diagnostic Centre , Mosaic Company , Delta Corp , Quess Corp , Equitas Holdings , Singapore Exchange , Dalal Street , Steel Strips , Steel Strips Wheels , Authum Investment , Smart Fill , Annual Report , Hitech Diagnostic Centre , Managing Director , Chief Executive Officer , Annual General Meeting , Federal Bank , Trip Planners , Executive Chairman Pirojsha Godrej ,

Metropolis Healthcare announces delay in acquisition of Hitech Diagnostic


Metropolis Healthcare had previously announced that the indicative period for the completion of acquisition of Dr.
Ganesan s Hitech Diagnostic Centre (Hitech) would be three months (3 months) from 17 January 2021. However, due to the urrent situation of COVID-19 pandemic as mutually agreed between both the parties, the aforementioned acquisition would be closed and completed within next 45 days.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19 ....

Ganesan Hitech Diagnostic Centre , Metropolis Healthcare , Hitech Diagnostic Centre , Capital Market , Ontemporary History , Hi Tech , Ovid 19 Pandemic , Ealth Information Technology For Economic And Clinical Health Act , Ganesans Hitech Diagnostic Centre , கணேசன் ஹைடெக் கண்டறியும் மையம் , பெருநகர சுகாதாரம் , ஹைடெக் கண்டறியும் மையம் , மூலதனம் சந்தை , விட் சர்வதேச பரவல் ,

Broker's call: Metropolis (Add) - The Hindu BusinessLine


Broker s call: Metropolis (Add)
|
Updated on
CMP: ₹2225.00
The company has announced its acquisition of 100 per cent stake in Dr. SP Ganesan’s Hitech Diagnostic Centre (Hitech) in a cash and stock deal. Hitech is a leading player in South India (primarily Chennai and Bengaluru), with a network of 31 labs and 68 collection centers.
This acquisition will help Metropolis in strengthening its presence in South India, improving B2C contribution as Hitech has higher B2C proportion in revenue and in driving potential cost synergies in coming years.
Hitech had revenue of ₹83.30 crore in FY20, with EBITDA margin similar to Metropolis. 9M-FY21 revenue is up about 50 per cent, aided by Covid-19 related tests with higher EBITDA margin. We assume 40 per cent revenue growth in FY21 and flat FY22 revenue as Covid-19 contribution will decelerate in our view. ....

Tamil Nadu , Sp Ganesan Hitech Diagnostic Centre , Hitech Diagnostic Centre , South India , Icici Securities , Hi Tech , Equity Shares , தமிழ் நாடு , ஸ்ப் கணேசன் ஹைடெக் கண்டறியும் மையம் , ஹைடெக் கண்டறியும் மையம் , தெற்கு இந்தியா , இஸிசீ பத்திரங்கள் , வணக்கம் தொழில்நுட்பம் , பங்கு பங்குகள் ,